Beyond the Hamilton depression scores in long-term treatment of manic-melancholic patients: prediction of recurrence of depression by quality of life measurements.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 8657843)

Published in Psychother Psychosom on January 01, 1995

Authors

K Thunedborg1, C H Black, P Bech

Author Affiliations

1: Frederiksborg General Hospital, Psychiatric Institute, Hillerød, Denmark.

Articles by these authors

(truncated to the top 100)

Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol (1998) 5.15

The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl (1987) 4.49

The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 3.37

Mini-compendium of rating scales for states of anxiety depression mania schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand Suppl (1986) 2.19

Quantitative rating of depressive states. Acta Psychiatr Scand (1975) 2.00

The SCL-90 and SCL-90R versions validated by item response models in a Danish community sample. Acta Psychiatr Scand (2004) 1.85

The internal and external validity of the Major Depression Inventory in measuring severity of depressive states. Psychol Med (2003) 1.80

The Danish SF-36 Health Survey: translation and preliminary validity studies. J Clin Epidemiol (1998) 1.77

Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center. Pain (1997) 1.75

The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale. Acta Psychiatr Scand (1979) 1.70

Comparison of Rasch and summated rating scales constructed from SF-36 physical functioning items in seven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.69

The mania rating scale: scale construction and inter-observer agreement. Neuropharmacology (1978) 1.66

Quality of life in the Danish general population--normative data and validity of WHOQOL-BREF using Rasch and item response theory models. Qual Life Res (2004) 1.59

Prevalence of major depression and stress indicators in the Danish general population. Acta Psychiatr Scand (2004) 1.59

Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand (1996) 1.55

Treatment outcome of chronic non-malignant pain patients managed in a danish multidisciplinary pain centre compared to general practice: a randomised controlled trial. Pain (2000) 1.53

Measuring psychotic depression. Acta Psychiatr Scand (2013) 1.52

The heterogeneity of the depressive syndrome: when numbers get serious. Acta Psychiatr Scand (2011) 1.51

Use of normal probability paper in determining thermal melting values of deoxyribonucleic acid. Can J Microbiol (1968) 1.45

Differential item functioning in the Danish translation of the SF-36. J Clin Epidemiol (1998) 1.44

The Hamilton depression scale. Evaluation of objectivity using logistic models. Acta Psychiatr Scand (1981) 1.43

How to manage mania not responding to a first-step 2 weeks treatment with quetiapine--a report from a prematurely discontinued randomised clinical trial. Acta Psychiatr Scand (2009) 1.41

Fatigue in the Danish general population. Influence of sociodemographic factors and disease. J Epidemiol Community Health (2000) 1.30

Evaluation of filters for removal of bacteriophages from air. Appl Microbiol (1966) 1.25

Reliability, validity and psychometric properties of the Greek translation of the Zung Depression Rating Scale. BMC Psychiatry (2001) 1.21

Reliability, validity and psychometric properties of the Greek translation of the Center for Epidemiological Studies-Depression (CES-D) Scale. BMC Psychiatry (2001) 1.17

Validation of the Bech-Rafaelsen Melancholia Scale and the Hamilton Depression Scale in patients with major depression; is the total score a valid measure of illness severity? Acta Psychiatr Scand (2005) 1.16

Using managerial role motivation theory to predict career success. Health Care Manage Rev (1987) 1.13

Rating scales for affective disorders: their validity and consistency. Acta Psychiatr Scand Suppl (1981) 1.13

Depression assessed over 1-year survival in patients with myocardial infarction. Acta Psychiatr Scand (2006) 1.11

Are in-patient depressives more often of the melancholic subtype? Danish University Antidepressant Group. Acta Psychiatr Scand (1998) 1.08

The BPRS: psychometric developments. Psychopharmacol Bull (1988) 1.08

Imipramine: clinical effects and pharmacokinetic variability. Psychopharmacology (Berl) (1977) 1.07

Is the antidepressive effect of second-generation antidepressants a myth? Psychol Med (2010) 1.07

Validity and utility of the Japanese version of the WHO-Five Well-Being Index in the context of detecting suicidal ideation in elderly community residents. Int Psychogeriatr (2006) 1.06

Mental distress in the Danish general population. Acta Psychiatr Scand (2006) 1.05

The WHO Quality of Life (WHOQOL) Questionnaire: Danish validation study. Nord J Psychiatry (2001) 1.01

Anxiety and depression in breast cancer patients at low risk of recurrence compared with the general population: a valid comparison? J Clin Epidemiol (1999) 0.99

Steady-state concentrations of imipramine and its metabolites in relation to the sparteine/debrisoquine polymorphism. Eur J Clin Pharmacol (1986) 0.98

Reliability, validity and psychometric properties of the Greek translation of the Major Depression Inventory. BMC Psychiatry (2003) 0.98

Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial. Pharmacopsychiatry (2008) 0.97

Plasma antipyrine half-life and hepatic microsomal antipyrine hydroxylase activity in rabbits. Pharmacology (1973) 0.96

Adjunctive bright light in non-seasonal major depression: results from clinician-rated depression scales. Acta Psychiatr Scand (2005) 0.95

Clinical characterization of patients with chronic tension headache. Headache (1988) 0.92

Clomipramine and mianserin in chronic idiopathic pain syndrome. A placebo controlled study. Psychopharmacology (Berl) (1989) 0.92

Quality of life after anterior resection versus abdominoperineal extirpation for rectal cancer. Scand J Gastroenterol (2002) 0.92

The full story of lithium. A tribute to Mogens Schou (1918-2005). Psychother Psychosom (2006) 0.91

Plasma levels and antidepressive effect of imipramine. Clin Pharmacol Ther (1976) 0.91

Diagnostic criteria for use in psychosomatic research. Psychother Psychosom (1995) 0.91

Lithium treatment and weight gain. Acta Psychiatr Scand (1976) 0.90

Depression: influence on time estimation and time experiments. Acta Psychiatr Scand (1975) 0.90

Internal and external validity of the WHO Well-Being Scale in the elderly general population. Acta Psychiatr Scand (1999) 0.90

Modern psychometrics in clinimetrics: impact on clinical trials of antidepressants. Psychother Psychosom (2004) 0.89

Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia. Amisulpride study group. Psychiatry Res (1999) 0.89

The Hamilton Anxiety Scale. Evaluation of homogeneity and inter-observer reliability in patients with depressive disorders. J Affect Disord (1983) 0.88

Psychosocial predictors of depression in patients with acute coronary syndrome. Acta Psychiatr Scand (2005) 0.87

Satisfaction with care reported by psychiatric inpatients. Relationship to diagnosis and medical treatment. Acta Psychiatr Scand (1993) 0.87

Neuroticism in relation to recovery and persisting pain after laparoscopic cholecystectomy. Scand J Gastroenterol (1998) 0.87

Therapeutic potentials of recently introduced antidepressants. Danish University Antidepressant Group. Psychopharmacol Ser (1993) 0.87

Misclassification and the use of register-based indicators for depression. Acta Psychiatr Scand (2008) 0.86

Simulated car driving influenced by cannabis and alcohol. Pharmakopsychiatr Neuropsychopharmakol (1973) 0.86

The St. Hans Rating Scale for extrapyramidal syndromes: reliability and validity. Acta Psychiatr Scand (1993) 0.86

Struggle for subtypes in primary and secondary depression and their mode-specific treatment or healing. Psychother Psychosom (2010) 0.86

Steady-state levels of imipramine and its metabolites: significance of dose-dependent kinetics. Eur J Clin Pharmacol (1986) 0.86

Morning and evening plasma melatonin and dexamethasone suppression test in patients with nonseasonal major depressive disorder from northern Greece (latitude 40-41.5 degrees ). Neuropsychobiology (2001) 0.86

Post-stroke depression: combined treatment with imipramine or desipramine and mianserin. A controlled clinical study. Psychopharmacology (Berl) (1994) 0.85

Experiments on clinical observation and judgement in the assessment of depression: profiled videotapes and Judgement Analysis. Psychol Med (1986) 0.84

Clomipramine and mianserin in the treatment of chronic tension headache. A double-blind, controlled study. Headache (1990) 0.84

Otologic symptoms in chronic renal failure. The possible role of aminoglycoside-furosemide interaction. Arch Otorhinolaryngol (1976) 0.84

The Ham D(6) is more homogenous and as sensitive as the Ham D(17). Eur Psychiatry (2007) 0.83

Personality in depression: concordance between clinical assessment and questionnaires. Acta Psychiatr Scand (1986) 0.82

A collaborative study of genetic linkage of bipolar manic-depressive illness and red/green colorblindness. A project of the biological psychiatry collaborative program of the world health organization. Acta Psychiatr Scand (1980) 0.82

The Brief Psychiatric Rating Scale. Dimension of schizophrenia--reliability and construct validity. Psychopathology (1989) 0.82

Cannabis and alcohol: effects on stimulated car driving. Science (1973) 0.82

The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry (2003) 0.82

Methods of evaluation of psychoactive drugs. Recenti Prog Med (1989) 0.82

The development of an observer-scale for measuring social dysfunction and aggression. Pharmacopsychiatry (1990) 0.82

Quality of life instruments in depression. Eur Psychiatry (1997) 0.82

Relapse prevention by citalopram in SAD patients responding to 1 week of light therapy. A placebo-controlled study. Acta Psychiatr Scand (2004) 0.81

The Melancholia Scale and the Newcastle Scales. Item-combinations and inter-observer reliability. Br J Psychiatry (1983) 0.81

Modafinil augmentation in depressed patients with partial response to antidepressants: a pilot study on self-reported symptoms covered by the Major Depression Inventory (MDI) and the Symptom Checklist (SCL-92). Nord J Psychiatry (2005) 0.81

Self- and observer assessment in anxiolytic drug trials: a comparison of their validity. Eur Arch Psychiatry Clin Neurosci (1990) 0.81

Social Adaptation Self-evaluation Scale (SASS): Psychometric analysis as outcome measure in the treatment of patients with major depression in the remission phase. Int J Psychiatry Clin Pract (2002) 0.81

Mental illness and simulated driving: before and during treatment. Pharmakopsychiatr Neuropsychopharmakol (1975) 0.80

Discomfort or disability in patients with chronic pain syndrome. Psychother Psychosom (1987) 0.80

Steady-state kinetics of imipramine in patients. Psychopharmacology (Berl) (1977) 0.80

The Marke-Nyman temperament scale. Evaluation of transferability using the Rasch item analysis. Acta Psychiatr Scand (1978) 0.79

Cannabis: a psychopharmacological review. Dan Med Bull (1974) 0.79

Treatment of unipolar major depression: Algorithms for pharmacotherapy. Int J Psychiatry Clin Pract (1997) 0.79

Identifying patients with therapy-resistant depression by using factor analysis. Pharmacopsychiatry (2010) 0.79

Assessment of symptom change from improvement curves on the Hamilton depression scale in trials with antidepressants. Psychopharmacology (Berl) (1984) 0.79

Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study. Acta Psychiatr Scand Suppl (1991) 0.79

The Hamilton disorders. Psychother Psychosom (1993) 0.78

Ménière's disease: lithium treatment (demonstration of placebo effect in a doubleblind cross-over trial). Clin Otolaryngol Allied Sci (1979) 0.78

Paroxetine and amitriptyline in the treatment of depression in general practice. Acta Psychiatr Scand (1996) 0.78

A multidimensional study of personality traits ad modum Sjöbring. Acta Neurol Scand (1976) 0.78

Synaptic membrane protein D2 in the cerebrospinal fluid of manic-melancholic patients. Acta Psychiatr Scand (1977) 0.78

The validity of Eysenck's neuroticism dimension within the Minnesota Multiphasic Personality Inventory in patients with duodenal ulcer. The Hvidovre Ulcer Project Group. Psychother Psychosom (1994) 0.78

The sufficiency of the HAM-D6 as an outcome instrument in the acute therapy of antidepressants in the outpatient setting. Int J Psychiatry Clin Pract (2007) 0.78

Adjunctive bright light in non-seasonal major depression: results from patient-reported symptom and well-being scales. Acta Psychiatr Scand (2005) 0.78